Home > Industry News
News Category

Can NMN fight cancer?

Views : 53
Update time : 2020-11-06 19:40:47
Can NMN fight cancer?

Q: Can NMN fight cancer?
Answer: Yes.

The formation and prevention of cancer cells (by Shanhai Cosroma):

First, the root cause of cancer is mutations after gene damage, and the body's own repair genes are weakened. When cells repair genes, they need to consume coenzyme Ⅰ (NAD+) to generate a variety of gene-repairing enzymes including PARP1. These enzymes also need to continuously consume energy when repairing genes.

If the level of Coenzyme I (NAD+) is low, the damaged gene cannot be repaired in time, and it may develop into cancer. NMN increases the level of Coenzyme I (NAD+), accelerates gene repair, and can effectively prevent cancer.

Second, cells whose genetic mutations have not been repaired have not undergone apoptosis, nor have they been recognized and destroyed by the immune system. Further reproduction may also develop into cancer.

The immune system needs Coenzyme Ⅰ (NAD+) to catalyze a variety of metabolic processes and a lot of energy to recognize and attack mutant cells. If the level of coenzyme Ⅰ (NAD+) is low, the immunity is decreased, and the energy is insufficient, the cancer cells cannot be eliminated in time. Therefore, NMN can increase the level of Coenzyme I (NAD+) and improve immunity, which can effectively prevent cancer.

Third, when cancer patients undergo radiotherapy, chemotherapy and other treatments, in addition to cancer cells are killed, normal cells are also severely damaged, and normal cells need to be multiplied to fill the gaps. In the case of very weak body, if the physique cannot be improved quickly, the remaining cancer cells are likely to die and recover.

Therefore, supplementation of NMN can quickly increase the level of Coenzyme I (NAD+), increase the overall metabolism of the body, help the body to speed up recovery, fight against the few remaining cancer cells, and effectively prevent cancer recurrence.

Professor David Sinclair of Harvard Medical School is currently conducting human clinical trials of NMN anti-cancer. It is expected that NMN-based anti-cancer drugs will be available in 3-5 years.